Product Information
MESALAMINE 800 MG DR TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $4.3205 per EA under NDC 00480775080. Its NADAC has been published 92 times since Sep 25, 2024.
Strength
800 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480775080
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MESALAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA213191On Market Since
8/22/2024
Pharmacological Classes
Price Statistics
The NADAC for MESALAMINE 800 MG DR TABLET has been published 92 times since Sep 25, 2024, and over the history we have for it it has declined 24.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.3205 per EA |
|---|---|
| All-time high | $5.8207 (Nov 13, 2024) |
| All-time low | $4.2583 (Apr 22, 2026) |
| 52-week high | $4.7363 |
| 52-week low | $4.2583 |
| Median price | $4.7096 |
| Average price | $4.9043 |
| Largest weekly change | -8.2% (Jun 18, 2025) |
| Weeks tracked | 92 |
| Tracking since | Sep 25, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MESALAMINE 800 MG DR TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MESALAMINE 800 MG DR TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $4.3205 per EA (NDC 00480775080), effective Jun 24, 2026.
How has the price of MESALAMINE 800 MG DR TABLET changed over time?
Over the history we have for it, the NADAC for MESALAMINE 800 MG DR TABLET has declined 24.4%. It has been tracked across 92 weekly CMS publications since Sep 25, 2024.
What are the highest and lowest recorded NADAC prices for MESALAMINE 800 MG DR TABLET?
Since Sep 25, 2024, the NADAC for MESALAMINE 800 MG DR TABLET has ranged from a low of $4.2583 (Apr 22, 2026) to a high of $5.8207 (Nov 13, 2024), with a median of $4.7096 per EA.
Are there cheaper alternatives to MESALAMINE 800 MG DR TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as MESALAMINE 800 MG DR TABLET, but none are currently priced below it.
Who manufactures MESALAMINE 800 MG DR TABLET?
MESALAMINE 800 MG DR TABLET (NDC 00480775080) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification